Delivery Order SPE2DB22D1002-SPE2DB24FKYW2
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the ROTATEQ VACCINE 2ML product. The $2,474.49 order is part of Amerisourcebergen's broader indefinite delivery contract with DLA, valued up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $15,765.90 contract is for the supply of the ROTATEQ vaccine, a 2 ml dosage form, with a performance period through March 13, 2024. This delivery order is issued under a single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $16,057.96 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the ROTATEQ Vaccine 2ML. This award was made under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables AmerisourceBergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,075.72 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide ROTATEQ VACCINE 2ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $9,784.81 order is for the ROTATEQ vaccine, a 2 milliliter dose of the rotavirus vaccine, with a completion date of December 18, 2023. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government...
- This is a $2,663.95 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTATEQ vaccine. The delivery order is not set aside and has an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global...
- The Defense Logistics Agency Troop Support Medical awarded a $21,495.25 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561446746 ROTATEQ Vaccine 2ML. The place of performance is Conshohocken, Pennsylvania, with work to be completed by July 11, 2023 under the contract. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No major subcontractors or set aside designations were indicated....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,536.32 order is for the supply of the ROTATEQ vaccine, a 2ml vaccine product, with a completion date of January 24, 2024. This delivery order is part of Amerisourcebergen Drug Corp's broader prime contract work providing pharmaceuticals, medical supplies, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.58 firm fixed-price delivery order is for the ROTATEQ vaccine, a vaccine for the prevention of rotavirus gastroenteritis in children. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 2 ml doses of the ROTATEQ vaccine. The $2,071.02 contract has a completion date of January 11, 2024 and will be performed at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a prime contractor that has previously received multiple awards from DLA Troop Support...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FKYW2Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the ROTATEQ VACCINE 2ML. The $17,070.82 order has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This order is issued under an indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 3/5/24 |